Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat

Citation
A. Szabo et al., Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat, KIDNEY INT, 57(3), 2000, pp. 982-991
Citations number
58
Categorie Soggetti
Urology & Nephrology","da verificare
Journal title
KIDNEY INTERNATIONAL
ISSN journal
00852538 → ACNP
Volume
57
Issue
3
Year of publication
2000
Pages
982 - 991
Database
ISI
SICI code
0085-2538(200003)57:3<982:EOAEIO>2.0.ZU;2-B
Abstract
Background. Despite considerable progress in immunosuppression, the inciden ce of chronic renal allograft rejection has not decreased. Recent studies h ave revealed that angiotensin-converting enzyme (ACE) inhibition ameliorate s graft arteriosclerosis. glomerulosclerosis and tubular atrophy. Moreover. it decreases systemic and glomerular capillary hydrostatic pressure in a r at kidney allograft model. We evaluated the effects of the ACE inhibitor en alapril on cytokine and growth factor expression in chronically rejecting r at kidney allografts. Methods. Kidneys of Fisher (F344) rats were orthotopically transplanted int o Lewis (Lew) rats. To prevent acute rejection. cyclosporine A (1.5 mg/kg/d ay) was given to all recipients during the first 10 days after transplantat ion. Enalapril (60 mg/L) or vehicle was added to the drinking water 10 days after transplantation. Animals were harvested 20 weeks after transplantati on for histologic and immunohistologic studies, as well as for evaluation o f cytokine and growth factor mRNA by semiquantitative polymerase chain reac tion. Results. Controls developed severe signs of chronic rejection. such as glom erular and vascular lesions, associated with a large number of infiltrating leukocytes. Enalapril-treated animals developed less proteinuria and other signs of chronic rejection. The mRNA levels of transforming growth factor- beta(1) (TGF-beta(1)), platelet-derived growth factor A and B chain (PDGF A and B), insulin-like growth factor-I (IGF-I). interleukin-1 (IL-1), and mo nocyte chemoattractant protein-1 (MCP-1) were significantly reduced in the enalapril group and were most pronounced for IL-1 and PDGF A. In addition. we found an increased level of renal angiotensinogen mRNA after treatment w ith enalapril. Conclusions. Treatment with enalapril attenuated the development of protein uria. ameliorated morphological damage, decreased leukocyte infiltration. a nd prevented a rise in renal mRNA levels of growth factors and cytokines in kidney grafts in a rat model of chronic renal allograft rejection.